Impact of L5–S1 Interbody Fusion on Neural and Functional Outcomes, as well as Radiological Fusion Rate After Lumbosacral Instrumentation for Lumbar Canal Stenosis: A Randomized Clinical Trial, Phase 2 Study
Journal of Neurorestoratology · 2026-10 · 100346
DOI: 10.1016/j.jnrt.2026.100346 ↗Kurz gefasst
Randomisierte kontrollierte Studie in der Zeitschrift Journal of Neurorestoratology, 2026-10. Verfasst von Reza Nasiri Mianroodi und 5 weiteren Autor:innen. Die Arbeit nennt 15 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0).
Abstract (Originalsprache)
Background
The clinical and radiological benefits of adding L5–S1 posterior interbody fusion to posterior instrumented lumbosacral fusion terminating at S1 for lumbar canal stenosis (LCS) remains incompletely defined. Therefore, we conducted a phase II randomized trial to evaluate whether L5–S1 interbody augmentation improves early fusion rates and functional recovery.
Methods
In this phase II, prospective, single-blind, randomized controlled clinical trial, adult participants with symptomatic lumbar canal stenosis (LCS) having indications for posterior decompression, fixation, and fusion including S1 level were allocated randomly in two groups to undergo, laminectomy and posterolateral fusion either with or without L5–S1 posterior interbody fusion utilizing harvested autograft. The therapeutic goals were either radiographic fusion rate at 6 months’ follow-up, assessed using the Brantigan–Steffee grading system (with grades D or E as indications of acceptable fusion), and the improvement in the Oswestry Disability Index (ODI) and Medical Research Council (MRC) motor grading from pre-operative to 6 months’ postoperative scores. Secondary assessments included the Visual Analog Scale (VAS) for back and leg pain, patient satisfaction, and reported post-operative complications.
Results
In this study, thirty-two patients were allocated into two equal groups including posterior spinal fixation (PSF) versus PSF+ L5−S1 interbody fusion assigned as treatment arms. There were no significant differences between the two groups concerning demographic and clinical characteristics. Furthermore, there were no significant differences duration of surgery, or post-operative complications except intraoperative bleeding volume. The mean ODI decreased from 34.9 to 9.6 in the interbody fusion group while from 37.9 to 14.7 in the PSF alone group. Although the interbody augmentation group showed a greater ODI reduction, the difference did not reach conventional statistical significance ( p = 0.071). At six months, Brantigan–Steffee class D (near complete fusion) plus E (complete fusion) was observed in 6 out of 16 patients (37.0%) in the interbody group compared to 12 out of 16 patients (75.0%) in the PSF alone group in the PSF+ L5−S1 interbody fusion compared with PSF alone was odds ratio of 1.67 (95% CI: 0.38–7.29) and Brantigan class E fusion was observed in 4 out of 16 patients (25.0%) in the interbody group compared to 1 out of 16 patients (6.25%) in the PSF alone group, with an adjusted odds ratio of 4.27 (95% CI: 0.40–45.9) for class E fusion in interbody fusion group. Neurological recovery, assessed by MRC, showed motor improvement in 5/11 (45.5%) patients in the interbody group versus 1/10 (10.0%) in the PSF-alone group ( p = 0.149).
Conclusions
The interbody augmentation was associated with increased operative time and blood loss; however, adverse events were infrequent and in accordance with expected complications rates, associated with possible improved neurological recovery.
Zitieren
APA
Mianroodi, R. N., Derakhshanrad, N., Yekaninejad, M. S., Ostadrahimi, N., Amirkhan, M. S., & Saberi, H. (2026). Impact of L5–S1 Interbody Fusion on Neural and Functional Outcomes, as well as Radiological Fusion Rate After Lumbosacral Instrumentation for Lumbar Canal Stenosis: A Randomized Clinical Trial, Phase 2 Study. Journal of Neurorestoratology, 100346. https://doi.org/10.1016/j.jnrt.2026.100346
Vancouver
Mianroodi RN, Derakhshanrad N, Yekaninejad MS, Ostadrahimi N, Amirkhan MS, Saberi H. Impact of L5–S1 Interbody Fusion on Neural and Functional Outcomes, as well as Radiological Fusion Rate After Lumbosacral Instrumentation for Lumbar Canal Stenosis: A Randomized Clinical Trial, Phase 2 Study. Journal of Neurorestoratology. 2026:100346. doi:10.1016/j.jnrt.2026.100346
BibTeX
@article{Mianroodi2026,
author = {Mianroodi, Reza Nasiri and Derakhshanrad, Nazi and Yekaninejad, Mir Saeed and Ostadrahimi, Nima and Amirkhan, Mahmoud Shehni and Saberi, Hooshang},
title = {Impact of L5–S1 Interbody Fusion on Neural and Functional Outcomes, as well as Radiological Fusion Rate After Lumbosacral Instrumentation for Lumbar Canal Stenosis: A Randomized Clinical Trial, Phase 2 Study},
journal = {Journal of Neurorestoratology},
year = {2026},
pages = {100346},
doi = {10.1016/j.jnrt.2026.100346}
}
EUVIMED